These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27098820)

  • 21. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis.
    Karpouzas GA; Ormseth SR; van Riel PLCM; Gonzalez-Gay MA; Corrales A; Rantapää-Dahlqvist S; Sfikakis PP; Dessein P; Tsang L; Hitchon C; El-Gabalawy H; Pascual-Ramos V; Contreras-Yáñez I; Colunga-Pedraza IJ; Galarza-Delgado DA; Azpiri-Lopez JR; Semb AG; Misra DP; Hauge EM; Kitas G
    RMD Open; 2024 Jul; 10(3):. PubMed ID: 39043615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME; Hsia E; Aletaha D
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial.
    Ried-Larsen M; Christensen R; Hansen KB; Johansen MY; Pedersen M; Zacho M; Hansen LS; Kofoed K; Thomsen K; Jensen MS; Nielsen RO; MacDonald C; Langberg H; Vaag AA; Pedersen BK; Karstoft K
    BMJ Open; 2015 Dec; 5(12):e009764. PubMed ID: 26656025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
    Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; Liem AH; van de Geijn GM; van der Meulen N; Birnie E; van der Zwan EM; van Zeben J; Castro Cabezas M
    Ann Rheum Dis; 2019 Mar; 78(3):335-341. PubMed ID: 30610067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study.
    Bae SC; Kim J; Choe JY; Park W; Lee SH; Park YB; Shim SC; Lee SS; Sung YK; Choi CB; Lee SR; Park H; Ahn Y;
    Ann Rheum Dis; 2017 Jan; 76(1):65-71. PubMed ID: 26905864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health outcomes of patients with chronic disease managed with a healthcare kiosk in primary care: protocol for a pilot randomised controlled trial.
    Ng G; Tan SW; Tan NC
    BMJ Open; 2018 Mar; 8(3):e020265. PubMed ID: 29574445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
    Genovese MC; Kalunian K; Gottenberg JE; Mozaffarian N; Bartok B; Matzkies F; Gao J; Guo Y; Tasset C; Sundy JS; de Vlam K; Walker D; Takeuchi T
    JAMA; 2019 Jul; 322(4):315-325. PubMed ID: 31334793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.
    Roelsgaard IK; Thomsen T; Østergaard M; Christensen R; Hetland ML; Jacobsen S; Andersen L; Tønnesen H; Rollefstad S; Semb AG; Esbensen BA
    Trials; 2017 Nov; 18(1):570. PubMed ID: 29183347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.
    Myasoedova E; Crowson CS; Kremers HM; Roger VL; Fitz-Gibbon PD; Therneau TM; Gabriel SE
    Ann Rheum Dis; 2011 Mar; 70(3):482-7. PubMed ID: 21216812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study.
    Monnet E; Choy EH; McInnes I; Kobakhidze T; de Graaf K; Jacqmin P; Lapeyre G; de Min C
    Ann Rheum Dis; 2020 Mar; 79(3):316-323. PubMed ID: 31892533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease.
    Sasso FC; Pafundi PC; Simeon V; De Nicola L; Chiodini P; Galiero R; Rinaldi L; Nevola R; Salvatore T; Sardu C; Marfella R; Adinolfi LE; Minutolo R;
    Cardiovasc Diabetol; 2021 Jul; 20(1):145. PubMed ID: 34271948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
    Hang Y; Qin X; Ren T; Cao J
    Lipids Health Dis; 2018 Jun; 17(1):146. PubMed ID: 29935544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder.
    Balogh E; Madruga Dias J; Orr C; Mullan R; Harty L; FitzGerald O; Gallagher P; Molloy M; O'Flynn E; Kelly A; Minnock P; O'Neill M; Moore L; Murray M; Fearon U; Veale DJ
    Arthritis Res Ther; 2013 Dec; 15(6):R221. PubMed ID: 24365061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study.
    Chen YL; Lin JZ; Mo YQ; Ma JD; Li QH; Wang XY; Yang ZH; Yan T; Zheng DH; Dai L
    Arthritis Res Ther; 2018 May; 20(1):81. PubMed ID: 29720221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes.
    Herly M; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Christensen R; Løgstrup BB; Vestergaard P; Pødenphant J; Junker P; Ellingsen T
    BMJ Open; 2017 Apr; 7(4):e014816. PubMed ID: 28391237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes.
    Huo X; Spatz ES; Ding Q; Horak P; Zheng X; Masters C; Zhang H; Irwin ML; Yan X; Guan W; Li J; Li X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    BMJ Open; 2017 Dec; 7(12):e018302. PubMed ID: 29273661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of rheumatoid arthritis following adjunct statin therapy.
    Das S; Mohanty M; Padhan P
    Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.